Literature DB >> 14755122

Factors affecting the formation of a skin reservoir for topically applied solutes.

M S Roberts1, S E Cross, Y G Anissimov.   

Abstract

The reservoir function of the skin is an important determinant of the duration of action of a topical solute. The reservoir can exist in the stratum corneum, in the viable avascular tissue (viable epidermis and supracapillary dermis) and in the dermis. A steroid reservoir in the stratum corneum has been demonstrated by the reactivation of a vasoconstrictor effect by occlusion or application of a placebo cream to the skin some time after the original topical application of steroid. Other solutes have also been reported to show a reservoir effect in the skin after topical application. A simple compartmental model is used to understand why reactivation of vasoconstriction some time after a topical steroid application shows dependency on time, topical solute concentration and the product used to cause reactivation. The model is also used to show which solutes are likely to show a reservoir effect and could be potentially affected by desquamation, especially when the turnover of the skin is abnormally rapid. A similar form of the model can be used to understand the promotion of reservoir function in the viable tissue and in the dermis in terms of effective removal by blood perfusing the tissues. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755122     DOI: 10.1159/000074057

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  10 in total

1.  Efficacy of skin wash on dermal absorption: an in vitro study on four model compounds of varying solubility.

Authors:  Jesper Bo Nielsen
Journal:  Int Arch Occup Environ Health       Date:  2010-05-26       Impact factor: 3.015

2.  Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.

Authors:  Sunny Kumar; Ming Chen; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

3.  Visualization of Epidermal Reservoir Formation from Topical Diclofenac Gels by Raman Spectroscopy.

Authors:  Qihong Zhang; Carol R Flach; Richard Mendelsohn; Leanne Page; Susan Whitson; Mila Boncheva Bettex
Journal:  J Pain Res       Date:  2020-07-02       Impact factor: 3.133

4.  Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis.

Authors:  William R Ravis; Alejandro Llanos-Cuentas; Nestor Sosa; Mara Kreishman-Deitrick; Karen M Kopydlowski; Carl Nielsen; Kirsten S Smith; Philip L Smith; Janet H Ransom; Yuh-Jing Lin; Max Grogl
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

5.  In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application.

Authors:  Ron Clijsen; Jean Pierre Baeyens; André Odilon Barel; Peter Clarys
Journal:  Drug Des Devel Ther       Date:  2015-02-13       Impact factor: 4.162

6.  The Pharmacokinetics of Fucoidan after Topical Application to Rats.

Authors:  Olga N Pozharitskaya; Alexander N Shikov; Ekaterina D Obluchinskaya; Heikki Vuorela
Journal:  Mar Drugs       Date:  2019-12-06       Impact factor: 5.118

7.  Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions.

Authors:  Esther Moreno; Alba Calvo; Juana Schwartz; Iñigo Navarro-Blasco; Elena González-Peñas; Carmen Sanmartín; Juan Manuel Irache; Socorro Espuelas
Journal:  Pharmaceutics       Date:  2019-11-13       Impact factor: 6.321

8.  Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis.

Authors:  Katrien Van Bocxlaer; Kerri-Nicola McArthur; Andy Harris; Mo Alavijeh; Stéphanie Braillard; Charles E Mowbray; Simon L Croft
Journal:  Pharmaceutics       Date:  2021-04-08       Impact factor: 6.321

Review 9.  Development of oxybutynin chloride topical gel for overactive bladder.

Authors:  Vincent R Lucente; David R Staskin; Elise De
Journal:  Open Access J Urol       Date:  2011-04-04

Review 10.  Oxybutynin topical gel in the treatment of overactive bladder.

Authors:  G Willy Davila
Journal:  Open Access J Urol       Date:  2010-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.